An observational study in Choledocholithiasis With Cholecystitis and Biliary Stones, sponsored by Assiut University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-04-02.
Sponsored by Assiut University · Observational
Chronic calculous cholecystitis is associated with common bile duct (CBD) stones in approximately 12% of patients. These patients need both cholecystectomy and CBD clearance of stones. The standard for cholecystectomy is laparoscopic cholecystectomy (LC) and the mostly common treatment used for CBD clearance is Endoscopic Retrograde Cholangiopancreatography (ERCP). The two interventions can be combined to be done at the same time under single anesthesia session. Studies of single stage ERCP+LC showed confirmed the safety and efficacy of the combined technique. However, some surgeons start with the ERCP while others start with LC.The aim of this study is to compare the start with ERCP followed by LC to the start with LC followed by ERCP when the two techniques are combined at the same session for treatment of chronic calculous cholecystitis associated with CBD stones regarding efficacy and safety of the two approaches.
88 studies on the registry are indexed under Cholecystolithiasis; 17 are open to participants now.
This study's enrollment of 115 is below the median of 341 across 28 observational studies indexed under Cholecystolithiasis.
Browse Cholecystolithiasis studies →Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients with chronic calculous cholecystitis associated with common bile duct (CBD) stones admitted in a tertiary care hospital
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The patients first underwent ERCP followed by standard 4 port LC.
Procedure: Laproscopic cholecystectomy (LC) · Procedure: Endoscopic Retrograde Cholangiopancreatography (ERCP)
The patients first underwent LC followed by ERCP.
Procedure: Laproscopic cholecystectomy (LC) · Procedure: Endoscopic Retrograde Cholangiopancreatography (ERCP)
Removal of gallbladder via laparoscopy
Removal of bile duct stones via endoscopy
Operative time operative time
total operative time of both ERCP+LC
Time frame: time in minutes from intubation of the patient to the end of procedure
CBD clearance rate
success rate of retrieval of stones
Time frame: up to 2 years
Length of hospital stay
days of hospital stay
Time frame: up to 2 weeks post-operative
Mortality rate
number of deaths intraoperative and postoperative related to surgery
Time frame: up to 1 month postoperative
Plan to share: No
This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.